Anna Dipietro
Psychiatric/Mental Health · Downingtown, PANPI 1952681322
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $97,163 of the $130,952 with a category attached, or 74.2%. AbbVie accounts for 74.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $41,827 and has fallen 52.9% since, to $19,712 in 2025. Among psychiatric/mental health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $584.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$98K
- Axsome Therapeutics, Inc.$33K
- E.r. Squibb & Sons, L.L.C.$55
- Corium, LLC$27
- Neos Therapeutics, LP$19
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$19
What the payments were for
- Consulting fees$21,67117%
- Speaking & faculty fees$97,16374%
- Travel & lodging$8,0836%
- Food & beverage$4,0363%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 165 | $97,810 |
| Axsome Therapeutics, Inc. | 54 | $33,022 |
| E.r. Squibb & Sons, L.L.C. | 2 | $55 |
| Corium, LLC | 1 | $27 |
| Neos Therapeutics, LP | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$130,952 in reported general payments places this provider in the 95th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 23 | $30,283 |
| Ziprasidone Hcl | 19 | $547 |
| Buspirone Hcl | 31 | $498 |
| Gabapentin | 17 | $251 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $245 |
| Oxcarbazepine | 12 | $192 |
| Sertraline Hcl | 16 | $186 |
| Clonazepam | 34 | $156 |
| Lamotrigine | 18 | $83 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $97,810 | $30,28323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
Other psychiatric/mental health in Downingtown
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Deena MasciocchiLanghorne$71K
- Joseph GagnonChesterbrook$64K
- Michelle CohenWashington$62K
- Sharon KatzJenkintown$51K
- Jennifer BowmanCanonsburg$48K
- Dylan KilmerGreenfield Township$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.